Cefazolin-13C2-15N
|
- $359 - $498
- Product name: Cefazolin-13C2-15N
- CAS: 2101505-58-0
- MF: C14H14N8O4S3
- MW: 457.53416
- EINECS:
- MDL Number:
- Synonyms:Cefazolin-13C2-15N;(6R,7R)-7-(2-(1H-tetrazol-1-yl-1-15N)acetamido-13C2-13C2)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
2 prices
Selected condition：
Brand
- AK Scientific
- Cayman Chemical
Package
- 1mg
- ManufacturerAK Scientific
- Product number7512DU
- Product description(6R,7R)-3-[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-((115N)tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
- Packaging1mg
- Price$498
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number25319
- Product descriptionCefazolin-13C2,15N ≥95%
- Packaging1mg
- Price$359
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 7512DU | (6R,7R)-3-[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-((115N)tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid | 1mg | $498 | 2021-12-16 | Buy |
| Cayman Chemical | 25319 | Cefazolin-13C2,15N ≥95% | 1mg | $359 | 2024-03-01 | Buy |
Properties
storage temp. :Store at -20°C
solubility :DMF: Soluble
form :A solid
solubility :DMF: Soluble
form :A solid
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | ||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||
| Precautionary statements: |
|
Description
Cefazolin-13C2,15N is intended for use as an internal standard for the quantification of cefazolin by GC- or LC-MS. Cefazolin is a broad-spectrum cephalosporin antibiotic that is active in vitro against various Gram-positive and Gram-negative bacteria (MICs = 0.2-12.5 μg/ml). It also inhibits the growth of clinical isolates of S. aureus, E. coli, P. mirabilis, and K. pneumoniae (MICs = 0.1-25 μg/ml). In vivo, cefazolin protects against S. aureus, E. coli, and P. mirabilis infection in mice (ED50s = <0.09-1.78, 0.44-3.63, and 2.31-5.2 mg/animal, respectively). Formulations containing cefazolin have been used to treat a variety of bacterial infections.Suppliers and manufacturers
Shanghai Hongye Biotechnology Co. Ltd
Shenzhen Polymeri Biochemical Technology Co., Ltd.
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Manhag Testing Technology Co., Ltd
QUALITY CONTROL SOLUTIONS LTD.
Guangzhou Austine Biotechnology Co., LTD
Shanghai Yifei Biotechnology Co. , Ltd.
TargetMol Chemicals Inc.